Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response

Vaccine

Volumn 25, Issue 36, 2007, Pages 6618-6624

  Hansen, Bethany ^a   Sokolovska, Anna ^b   HogenEsch, Harm ^b   Hem, Stanley L ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Adsorptive coefficient; Aluminum hydroxide adjuvant; Antigen adsorption; Elution; Ligand exchange; Strength of adsorption; T cell activation

Indexed keywords

ADJUVANT; ALPHA CASEIN; ALUMINUM HYDROXIDE; ANTIGEN; CASEIN; HYDROXYL GROUP; PHOSPHATE; REHYDRAGEL; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG FORMULATION; ELUTION; FEMALE; FORCE; IMMUNE RESPONSE; IMMUNOPOTENTIATION; IN VITRO STUDY; INTERSTITIAL FLUID; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; STRENGTH; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ADSORPTION; ALUMINUM HYDROXIDE; ANIMALS; ANTIBODY FORMATION; ANTIGENS; FEMALE; MICE; MICE, INBRED BALB C; SPLEEN; T-LYMPHOCYTES; TIME FACTORS; VACCINES;

EID: 34547699645     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.06.049     Document Type: Article

References (21)

1. Glenny A., Pope C., Waddington H., and Wallace V. The antigenic value of toxoid precipitated by potassium alum. J Path Bacterial 29 (1926) 38-45
2. Seeber S.J., White J.L., and Hem S.L. Predicting the adsorption of proteins by aluminum-containing adjuvants. Vaccine 9 (1991) 201-203
3. Iyer S., Robinett R.S., HogenEsch H., and Hem S.L. Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant. Vaccine 29 (2004) 1475-1479
4. Shi Y., HogenEsch H., and Hem S.L. Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines. Vaccine 20 (2002) 80-85
5. Jendrek S., Little S.F., Hem S., Mitra G., and Giardina S. Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants. Vaccine 21 (2003) 3011-3018
6. Chang M.-F., Shi Y., Nail S.L., HogenEsch H., Adams S.B., White J.L., et al. Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits. Vaccine 19 (2001) 2884-2889
7. Romero Mendez I.Z., Shi Y., HogenEsch H., and Hem S.L. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants. Vaccine 25 5 (2007) 825-833
8. Berthold I., Pombo M.L., Wagner L., and Arciniega J.L. Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants. Vaccine 23 16 (2005) 1993-1999
9. Morefield G.L., Jiang D., Romero-Mendez I.Z., Geahlen R.L., HogenEsch H., and Hem S.L. Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid. Vaccine 23 12 (2005) 1502-1506
10. Iyer S., HogenEsch H., and Hem S.L. Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins. Pharm Dev Technol 8 (2003) 81-86
11. Bigham E., Farrrell H.L., and Dahl K.J. Removal of phosphate groups from casein with acid phosphate. Biochim Biophys Acta 429 (1976) 448-460
12. Iyer S., HogenEsch H., and Hem S.L. Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production. Vaccine 21 11-12 (2003) 1219-1223
13. Jiang D., Morefield G.L., HogenEsch H., and Hem S.L. Relationship of adsorption mechanism of antigens by aluminum-containing adjuvants to in vitro elution in interstitial fluid. Vaccine 24 (2006) 1665-1669
14. Luca F.C., Bloom G.S., and Vallee R.B. A monoclonal antibody that cross-reacts with phosphorylated epitopes on two microtubule-associated proteins and two neurofilament polypeptides. PNAS 83 4 (1986) 1006-1010
15. Itano A.A., McSorley S.J., Reinhardt R.L., Ehst B.D., Ingulli E., Rudensky A.Y., et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19 1 (2003) 47-57
16. Watts C. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat Immunol 5 7 (2004) 685-692
17. Morefield G.L., Sokolovska A., Jiang D., HogenEsch H., Robinson J.P., and Hem S.L. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 23 13 (2005) 1588-1595
18. White R.G., Coons A.H., and Connolly J.M. Studies on antibody production. III. The alum granuloma. J Exp Med 102 (1955) 73-82
19. HogenEsch H. Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine 20 Suppl. 3 (2002) S34-S39
20. Lindblad E.B. Aluminum adjuvants-in retrospect and prospect. Vaccine 22 27-28 (2004) 3658-3668
21. Sturgess A.W., Rush K., Charbonneau R.J., Lee J.I., West D.J., Sitrin R.D., et al. Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide. Vaccine 17 (1999) 1169-1178